My bookmarksSign up free

Commission Implementing Regulation (EU) 2021/1322 of 3 August 2021 amending Implementing Regulation (EU) 2019/2076 to make administrative changes to the Union authorisation of the biocidal product family ‘Contec IPA Product Family’ (Text with EEA relevance)

Commission Implementing Regulation (EU) 2021/1322 of 3 August 2021 amending Implementing Regulation (EU) 2019/2076 to make administrative changes to the Union authorisation of the biocidal product family ‘Contec IPA Product Family’ (Text with EEA relevance)

Implementing Regulation (EU) 2021/1322 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Annex II to Implementing Regulation (EU) 2019/2076 is replaced by the text in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX ‘ANNEX II Summary of product characteristics for a biocidal product family Contec IPA Product Family Product type 2 – Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) Product type 4 – Food and feed area (Disinfectants) Authorisation number: EU-0020460-0000 R4BP asset number: EU-0020460-0000 PART I FIRST INFORMATION LEVEL 1.   ADMINISTRATIVE INFORMATION 1.1.    Family name Name Contec IPA Product Family 1.2.    Product type(s) Product type(s) PT02 – Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT04 – Food and feed area (Disinfectants) 1.3.    Authorisation holder Name and address of the authorisation holder Name Contec Europe Address Zl Du Prat, Avenue Paul Duplaix, 56000, Vannes, France Authorisation number EU-0020460-0000 R4BP asset number EU-0020460-0000 Date of the authorisation 26 December 2019 Expiry date of the authorisation 30 November 2029 1.4.    Manufacturer(s) of the biocidal products Name of manufacturer Contec Inc. Address of manufacturer 525 Locust Grove, SC 29303 Spartanburg United States Location of manufacturing sites 525 Locust Grove, SC 29303 Spartanburg United States Name of manufacturer Contec Cleanroom Technology (Suzhou) Co., Ltd. China Address of manufacturer 17 Longyun Road, Suzhou Industrial Park, 215024 Suzhou China Location of manufacturing sites 17 Longyun Road, Suzhou Industrial Park, 215024 Suzhou China Name of manufacturer Contec Cleanroom (UK) Ltd Address of manufacturer Unit 6A, Wansbeck Business Park, Rotary Parkway, NE63 8QW Ashington, Northumberland United Kingdom Location of manufacturing sites Unit 6A, Wansbeck Business Park, Rotary Parkway, NE63 8QW Ashington, Northumberland United Kingdom Name of manufacturer Flexible Medical Packaging Address of manufacturer Unit 8 Hightown, White Cross Industrial Estate, LA1 4XS Lancaster, Lancashire United Kingdom Location of manufacturing sites Unit 8 Hightown, White Cross Industrial Estate, LA1 4XS Lancaster, Lancashire United Kingdom 1.5.    Manufacturer(s) of the active substance(s) Active substance Propan-2-ol Name of manufacturer Brenntag GmbH Address of manufacturer Messeallee 11, 45131 Essen, Germany Location of manufacturing sites Haven 3222, Vondelingenweg 601, 3196 KK Vondelingenplaat Netherlands 2.   PRODUCT FAMILY COMPOSITION AND FORMULATION 2.1.    Qualitative and quantitative information on the composition of the family Common name IUPAC name Function CAS number EC number Content (%) Min Max Propan-2-ol   Active Substance 67-63-0 200-661-7 62,9 62,9 2.2.    Type(s) of formulation Formulation(s) AL (any other liquid) – RTU solution/trigger spray AL (any other liquid) – RTU wipe PART II SECOND INFORMATION LEVEL – META SPC(S) META SPC 1 1.   META SPC 1 ADMINISTRATIVE INFORMATION 1.1.    Meta SPC 1 identifier Identifier Contec IPA Liquid Products 1.2.    Suffix to the authorisation number Number 1-1 1.3.    Product type(s) Product type(s) PT02 – Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT04 – Food and feed area (Disinfectants) 2.   META SPC 1 COMPOSITION 2.1.    Qualitative and quantitative information on the composition of the meta SPC 1 Common name IUPAC name Function CAS number EC number Content (%) Min Max Propan-2-ol   Active Substance 67-63-0 200-661-7 62,9 62,9 2.2.    Type(s) of formulation of the meta SPC 1 Formulation(s) AL (any other liquid) – RTU solution/trigger spray 3.   HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 1 Hazard statements Highly flammable liquid and vapour. Causes serious eye irritation. May cause drowsiness or dizziness. Repeated exposure may cause skin dryness or cracking. Precautionary statements If medical advice is needed, have product container or label at hand. Keep out of reach of children. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Keep container tightly closed. Avoid breathing vapours. Wash hands thoroughly after handling. Use only outdoors or in a well-ventilated area. Wear eye protection. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. IF INHALED: Remove person to fresh air and keep comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a Poison centre if you feel unwell. If eye irritation persists: Get medical advice. In case of fire: Use alcohol resistant foam to extinguish. Store in a well-ventilated place. Keep cool. Store locked up. Dispose of contents/container in accordance with local regulations. 4.   AUTHORISED USE(S) OF THE META SPC 1 4.1.    Use description Table 1 Use # 1 – Professional use Product type PT02 – Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT04 – Food and feed area (Disinfectants) Where relevant, an exact description of the authorised use   Target organism(s) (including development stage) Bacteria Mycobacteria Yeasts Field(s) of use Indoor Disinfectant for use against bacteria, mycobacteria and yeast on hard, non-porous surfaces in cleanrooms for biotechnology, pharmaceutical, manufacture of medical devices, healthcare industries and other critical life science applications, and in industrial food and feed preparation areas. Acceptable use temperature: room temperature (20 ± 2 °C) Application method(s) Spraying and wiping Application rate(s) and frequency 50 ml product per m 2 of surface. Wiping: 1 minute contact time for bacteria and myobacteria 3 minutes contact time for yeast Category(ies) of users Professional Pack sizes and packaging material High-density polyethylene (HDPE) trigger spray bottle – 0,5 L – 1 L HDPE capped refill bottle – 5 L 4.1.1.    Use-specific instructions for use See general directions for use 4.1.2.    Use-specific risk mitigation measures See general directions for use 4.1.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use 4.1.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use 4.1.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use 5.   GENERAL DIRECTIONS FOR USE  ( 1 ) OF THE META SPC 1 5.1.    Instructions for use Use at room temperature. For visibly soiled surfaces, cleaning prior to disinfection is required. Wiping: Apply/Spray product to a suitable quality cleanroom wipe. Ensure the wipe is sufficiently and uniformly saturated before wiping the surface to be disinfected. Ensure the surface is uniformly covered with the product then wipe to dry with a sterile cleanroom wipe. Contact times: Wiping 1 minute for bacteria and mycobacteria 3 minutes for yeast. Used wipes must be disposed of in a closed container. 5.2.    Risk mitigation measures Wash hands and exposed skin before meals and after use. Avoid contact with eyes “For use in cleanrooms, adequate technical/engineering controls to remove airborne residues is mandatory e.g. room ventilation or LEV” 5.3.    Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment Likely direct or indirect adverse effects: Headache, vertigo, hallucinations, respiratory depression, CNS depression or coma. Severe irritation of the eyes and or ocular damage. Nausea, vomiting, diarrhoea and haemorrhagic gastritis. Pulmonary aspiration hazard may induce pneumonitis, hypotension and hypoglycaemia. First aid measures: Relocate the individual from the exposure source and remove any contaminated/spattered clothing articles. Eye contact: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention Skin contact; wash affected area with plenty of water and soap. No scrubbing. In case of ingestion: Do NOT induce vomiting and never give anything by mouth to an impaired or unconscious individual; if the individual is unconscious place individual in left sideways (recovery) position with the head lowered and the knees bent. Keep the individual calm and at rest, conserve body temperature and control breathing. If necessary check for pulse and initiate artificial respiration. Take the individual to a healthcare centre and bring packaging or label whenever possible. NEVER LEAVE THE AFFECTED INDIVIDUAL UNATTENDED! Advice for medical and healthcare personnel: Monitor vital signs and provide symptomatic and supportive treatment. Evaluate endoscopic procedure in case of ingestion. Monitor glycaemia and ketones. Ipecac use is contraindicated. WHEN ASKING FOR MEDICAL ADVICE KEEP PACKAGING OR LABEL AT HAND AND CALL YOUR LOCAL POISON CONTROL CENTRE ☐ [INSERT LOCAL NUMBER HERE]. 5.4.    Instructions for safe disposal of the product and its packaging Dispose of contents/container in accordance with local regulations. Do not re-use empty container for any other purpose. 5.5.    Conditions of storage and shelf-life of the product under normal conditions of storage Store in a cool, dry, well-ventilated place in original container. Keep away from sources of ignition. Keep away from direct sunlight. Keep container tightly closed. Shelf-life: 2 years 6.   OTHER INFORMATION The product contains propan-2-ol (CAS No: 67-63-0), for which an European reference value of 129,28 mg/m 3 for the professional user was agreed and used for the risk assessment of the product. 7.   THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 1 7.1.    Trade name(s), authorisation number and specific composition of each individual product Trade name(s) Contec IPA Contec Sterile IPA Authorisation number EU-0020460-0001 1-1 Common name IUPAC name Function CAS number EC number Content (%) Propan-2-ol   Active Substance 67-63-0 200-661-7 62,9 META SPC 2 1.   META SPC 2 ADMINISTRATIVE INFORMATION 1.1.    Meta SPC 2 identifier Identifier Contec IPA Wipes 1.2.    Suffix to the authorisation number Number 1-2 1.3.    Product type(s) Product type(s) PT02 – Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT04 – Food and feed area (Disinfectants) 2.   META SPC 2 COMPOSITION 2.1.    Qualitative and quantitative information on the composition of the meta SPC 2 Common name IUPAC name Function CAS number EC number Content (%) Min Max Propan-2-ol   Active Substance 67-63-0 200-661-7 62,9 62,9 2.2.    Type(s) of formulation of the meta SPC 2 Formulation(s) AL (any other liquid) – RTU wipe 3.   HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 2 Hazard statements Highly flammable liquid and vapour. Causes serious eye irritation. May cause drowsiness or dizziness. Repeated exposure may cause skin dryness or cracking. Precautionary statements If medical advice is needed, have product container or label at hand. Keep out of reach of children. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Keep container tightly closed. Avoid breathing vapours. Wash hands thoroughly after handling. Use only outdoors or in a well-ventilated area. Wear eye protection. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. IF INHALED: Remove person to fresh air and keep comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a POISON CENTRE if you feel unwell. If eye irritation persists: Get medical advice. In case of fire: Use alcohol resistant foam to extinguish. Store in a well-ventilated place. Keep cool. Store locked up. Dispose of contents/container in accordance with local regulations. 4.   AUTHORISED USE(S) OF THE META SPC 2 4.1.    Use description Table 2 Use # 1 – Professional use Product type PT02 – Disinfectants and algaecides not intended for direct application to humans or animals (Disinfectants) PT04 – Food and feed area (Disinfectants) Where relevant, an exact description of the authorised use - Target organism(s) (including development stage) Bacteria Mycobacteria Yeasts Field(s) of use Indoor Disinfectant for use against bacteria, mycobacteria and yeast on hard, non-porous surfaces in cleanrooms for biotechnology, pharmaceutical, manufacture of medical devices, healthcare industries and other critical life science applications, and in industrial food and feed preparation areas. Acceptable use temperature: room temperature (20 ± 2 °C) Application method(s) Wiping Application rate(s) and frequency 1 minute contact time for bacteria and mycobacteria 3 minutes contact time for yeast Category(ies) of users Professional Pack sizes and packaging material Impregnated 100 % polypropylene wipes in: — HDPE canister with HDPE cap – 150 wipes (1,7 L or 2,15 L) — Polyethylene terephthalate (PET)/polyethylene (PE) packet sealed with PET/PE flow wrap – 30, 40 or 50 wipes Impregnated 100 % polyester wipes in: — HDPE canister with HDPE cap – 100 wipes (2,25 L) — PET/PE packet sealed with PET/PE flow wrap – 20 wipes Impregnated 100 % knitted polyester wipes in: — PET/PE packet sealed with PET/PE flow wrap – 8, 10, 20, 30 or 50 wipes Impregnated 55 % cellulose/45 % polyester wipes in: — HDPE canister with HDPE cap – 100 wipes (2,25 L) — PET/PE packet sealed with PET/PE flow wrap – 24, 30, 50 or 75 wipes Impregnated 50 % rayon/50 % polyester wipes in: — HDPE canister with HDPE cap – 700 wipes (11,4 L) 4.1.1.    Use-specific instructions for use See general directions for use 4.1.2.    Use-specific risk mitigation measures See general directions for use 4.1.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use 4.1.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use 4.1.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use 5.   GENERAL DIRECTIONS FOR USE  ( 2 ) OF THE META SPC 2 5.1.    Instructions for use For soiled surfaces, cleaning prior to disinfection is required. Ensure the surface is uniformly covered with the product, allow to act for a contact time of 1 minute for bactericidal and mycobactericidal action and 3 minutes for yeasticidal action 5.2.    Risk mitigation measures Wash hands and exposed skin before meals and after use. Avoid contact with eyes “For use in cleanrooms, adequate technical/engineering controls to remove airborne residues is mandatory e.g. room ventilation or LEV” 5.3.    Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment Likely direct or indirect adverse effects: Headache, vertigo, hallucinations, respiratory depression, CNS depression or coma. Severe irritation of the eyes and or ocular damage. Nausea, vomiting, diarrhoea and haemorrhagic gastritis. Pulmonary aspiration hazard may induce pneumonitis, hypotension and hypoglycaemia. First aid measures: Relocate the individual from the exposure source and remove any contaminated/spattered clothing articles. Eye contact: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention Skin contact; wash affected area with plenty of water and soap, No scrubbing. In case of ingestion; Do NOT induce vomiting and never give anything by mouth to an impaired or unconscious individual; if the individual is unconscious place individual in left sideways (recovery) position with the head lowered and the knees bent. Keep the individual calm and at rest, conserve body temperature and control breathing. If necessary check for pulse and initiate artificial respiration. Take the individual to a healthcare centre and bring packaging or label whenever possible. NEVER LEAVE THE AFFECTED INDIVIDUAL UNATTENDED! Advice for medical and healthcare personnel: Monitor vital signs and provide symptomatic and supportive treatment. Evaluate endoscopic procedure in case of ingestion. Monitor glycaemia and ketones. Ipecac use is contraindicated. WHEN ASKING FOR MEDICAL ADVICE KEEP PACKAGING OR LABEL AT HAND AND CALL YOUR LOCAL POISON CONTROL CENTRE ☐ [INSERT LOCAL NUMBER HERE]. 5.4.    Instructions for safe disposal of the product and its packaging Dispose of contents/container in accordance with local regulations. Do not re-use empty container for any other purpose. Used wipes must be disposed in a closed container Dispose of used wipes by dry waste to landfill 5.5.    Conditions of storage and shelf-life of the product under normal conditions of storage Store in a cool, dry, well-ventilated place in original container. Keep away from sources of ignition. Keep away from direct sunlight. Keep container tightly closed. Shelf-life: 2 years 6.   OTHER INFORMATION Polypropylene, polyester, kitted polyester, 55 % cellulose/45 % polyester or 50 % rayon/50 % polyester wipes, 34-240 gsm, containing 5 – 38 ml product (2,75 – 20,9 g propan-2-ol) The product contains propan-2-ol (CAS No: 67-63-0), for which an European reference value of 129,28 mg/m 3 for the professional user was agreed and used for the risk assessment of the product. 7.   THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 2 7.1.    Trade name(s), authorisation number and specific composition of each individual product Trade name(s) PROSAT EasyReach PROSAT Sterile EasyReach PROSAT Wipes PROSAT Sterile Wipes SATWipes Wipes SATWipes Sterile Wipes Cleanroom wipes, presaturated Spec-Wipe Authorisation number EU-0020460-0002 1-2 Common name IUPAC name Function CAS number EC number Content (%) Propan-2-ol   Active Substance 67-63-0 200-661-7 62,9 ’ ( 1 )   Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 1. ( 2 )   Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses within the meta SPC 2.

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1392 of 15 July 2025 concerning the authorisation of a preparation of 3-phytase produced with Komagataella phaffii CECT 13171 as a feed additive for poultry species for fattening or reared for laying or for breeding, minor poultry species for breeding, laying hens and pigs for fattening of all Suidae species (holder of authorisation: Fertinagro Biotech S.L.)Commission Implementing Regulation (EU) 2025/1395 of 15 July 2025 correcting and amending Implementing Regulation (EU) 2020/997 as regards the terms of the authorisation of L-lysine base, liquid, as a feed additive for all animal speciesCouncil Implementing Regulation (EU) 2025/1396 of 15 July 2025 implementing Regulation (EU) 2020/1998 concerning restrictive measures against serious human rights violations and abusesCouncil Implementing Regulation (EU) 2025/1433 of 15 July 2025 implementing Regulation (EU) 2022/2309 concerning restrictive measures in view of the situation in HaitiCouncil Implementing Regulation (EU) 2025/1434 of 15 July 2025 implementing Regulation (EU) 2023/888 concerning restrictive measures in view of actions destabilising the Republic of MoldovaCouncil Implementing Regulation (EU) 2025/1438 of 15 July 2025 implementing Regulation (EU) 2024/1485 concerning restrictive measures in view of the situation in RussiaCouncil Implementing Regulation (EU) 2025/1444 of 15 July 2025 implementing Regulation (EU) 2024/2642 concerning restrictive measures in view of Russia’s destabilising activitiesCommission Implementing Regulation (EU) 2025/1448 of 15 July 2025 initiating an investigation concerning possible circumvention of the anti-dumping measures imposed by Implementing Regulation (EU) 2019/1259 on imports of threaded tube or pipe cast fittings of malleable cast iron, originating in the People’s Republic of China and Thailand by imports of unthreaded tube or pipe cast fittings of malleable cast iron originating in the People’s Republic of China and making such imports subject to registrationRegulation (EU) 2025/1520 of the European Central Bank of 15 July 2025 amending Regulation (EU) 2016/445 on the exercise of options and discretions available in Union law (ECB/2016/4) (ECB/2025/24)Commission Implementing Regulation (EU) 2025/1345 of 14 July 2025 correcting certain language versions of Annex I to Regulation (EU) No 1178/2011 laying down technical requirements and administrative procedures related to civil aviation aircrew pursuant to Regulation (EC) No 216/2008 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1401 of 14 July 2025 amending Annexes I, VIII, XI, XV, XVI and XVII to Implementing Regulation (EU) 2021/620 as regards the approval or withdrawal of the disease-free status of certain Member States, zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for certain listed diseasesCommission Implementing Regulation (EU) 2025/1492 of 14 July 2025 concerning the classification of certain goods in the Combined Nomenclature

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next